订阅小程序
旧版功能

Sequential Pembrolizumab and AVD Are Highly Effective at Any PD-L1 Expression Level in Untreated Hodgkin Lymphoma

Blood Advances(2022)

引用 16|浏览40
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要